These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Immunosuppressive therapy. Winkelstein A; Segel D; Stolzer BL; Fogel M; Shadduck RK; Lewis M Am J Med Sci; 1973 Feb; 265(2):92-108. PubMed ID: 4736193 [No Abstract] [Full Text] [Related]
6. [Introduction to the clinical use of immunosuppressive agents]. Bach JF Ann Med Interne (Paris); 1974 Oct; 125(10):697-702. PubMed ID: 4548812 [No Abstract] [Full Text] [Related]
7. [Immunosuppressive therapy in auto-immune diseases i. general fundamentals (author's transl)]. Sönnichsen N; Alberecht-Nebe H; Schulze P; Apostoloff E Dermatol Monatsschr; 1978 Nov; 164(11):769-78. PubMed ID: 363471 [No Abstract] [Full Text] [Related]
8. [Medicamental immunosuppression in dermatology (author's transl)]. Goerz G; Merk H Z Hautkr; 1981 Aug; 56(15):975-90. PubMed ID: 7269720 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological immunosuppressive agents. Salaman JR Ulster Med J; 1981; 50(Suppl 1):36-42. PubMed ID: 7015656 [No Abstract] [Full Text] [Related]
10. [Comparison of the immunosuppressive effects of 6-mercaptopurine, azathioprine, cyclophosphamide and 036.5122 (Asta) on primary and secondary immune reactions in the mouse]. Botzenhardt U; Lemmel EM Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1806-8. PubMed ID: 1030111 [No Abstract] [Full Text] [Related]
11. [Assessment of the effect of immunosuppression on leukocyte migration inhibition in various autoimmune diseases in children]. Lukas A; Cesarz E; Sliwa F; Lukas W; Sychłowy A Pediatr Pol; 1978 Nov; 53(11):1271-5. PubMed ID: 309586 [No Abstract] [Full Text] [Related]
12. Therapy of autoimmune nephropathy with steroids and cytostatics. A follow-up study of 80 patients and of 16 years. Petrányi G; Leövey A; Szegedi G; Kakuk G; Bobory J Acta Med Acad Sci Hung; 1971; 28(1):97-106. PubMed ID: 5133501 [No Abstract] [Full Text] [Related]
13. A critical analysis of the use of azathioprine in clinical medicine. Ten Berge RJ; Schellekens PT Neth J Med; 1983; 26(6):164-71. PubMed ID: 6350911 [No Abstract] [Full Text] [Related]
14. [Immunosuppressive therapy]. Fink U Med Klin; 1969 Jun; 64(23):1069-72. PubMed ID: 4185573 [No Abstract] [Full Text] [Related]
15. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate. Sandborn WJ Am J Gastroenterol; 1996 Mar; 91(3):423-33. PubMed ID: 8633486 [No Abstract] [Full Text] [Related]
16. Selective inhibition of inflammatory gene expression in activated T lymphocytes: a mechanism of immune suppression by thiopurines. Thomas CW; Myhre GM; Tschumper R; Sreekumar R; Jelinek D; McKean DJ; Lipsky JJ; Sandborn WJ; Egan LJ J Pharmacol Exp Ther; 2005 Feb; 312(2):537-45. PubMed ID: 15388785 [TBL] [Abstract][Full Text] [Related]
17. [Preliminary studies on immunosuppressive therapy of connective tissue disorders]. Gillardi U; Liso V; Troccoli G Haematologica; 1970 Dec; 55(12):759-65. PubMed ID: 5003115 [No Abstract] [Full Text] [Related]
18. [Immunotherapy today]. D'Amelio R Riv Med Aeronaut Spaz; 1977; 40(1-2):123-52. PubMed ID: 311930 [No Abstract] [Full Text] [Related]
19. [Long-term therapy of immunologic diseases with special reference to the use of immunosuppressive agents]. Scheiffarth F; Warnatz H Dtsch Med Wochenschr; 1969 Nov; 94(47):2444-9. PubMed ID: 4310731 [No Abstract] [Full Text] [Related]
20. [Use of immunosuppressive cytostatic agents in children's diseases in our experience]. Szotowa W; Ludwiczak H; Oknińska A; Zeligowska J; Serejska E Wiad Lek; 1969 Jan; 22(2):93-100. PubMed ID: 5780338 [No Abstract] [Full Text] [Related] [Next] [New Search]